The Centers for Disease Control and Prevention (CDC) confirmed Friday that there are currently no cases of the Andes virus in the United States, despite an ongoing outbreak linked to the MV Hondius cruise ship. While the agency is maintaining a rigorous CDC hantavirus response to track potentially exposed travelers, officials emphasized that the risk to the general American public remains extremely low.
The Andes virus is a specific strain of hantavirus found primarily in Argentina and Chile. Unlike most hantaviruses, which are typically contracted through contact with infected rodent droppings or urine, the Andes strain is the only known version of the virus capable of spreading from person to person. This unique characteristic has prompted the federal government to implement a strict monitoring protocol for a select group of U.S. Residents who may have been exposed during their travels.
During a press briefing on May 15, 2026, agency leaders detailed the steps being taken to ensure that the virus does not establish a foothold in the U.S. The response involves a high level of coordination between the White House, the Department of Health and Human Services and state and local health departments to monitor individuals who were on the cruise or in close proximity to infected passengers during air travel.
Understanding the Risk of the Andes Virus
To the general public, hantaviruses are often associated with rural environments and rodent exposure. In the U.S., the Sin Nombre virus is a common seasonal threat that typically sees an increase in cases during the spring and summer. However, Dr. David Fitter, the Incident Manager for the CDC’s hantavirus response, clarified that these routine domestic cases are entirely separate from the MV Hondius outbreak.
The Andes virus presents a different public health challenge because of its ability to transmit between humans through close, prolonged contact. While the virus does not spread easily, the potential for person-to-person transmission necessitates the current precautionary measures. In severe cases, the virus can lead to fatal lung disease, and because there is currently no vaccine or specific medical treatment, prevention through isolation is the primary tool for containment.
Strict Monitoring for High-Risk Contacts
The CDC has established a specific set of criteria to identify “high-risk” contacts. This group includes passengers who were aboard the MV Hondius between April 6, when the first case was identified, and May 10, when the final passengers disembarked. It also includes individuals who had close contact with the body fluids of an infected person or those seated in close proximity to a symptomatic passenger during flights.
Individuals identified as high-risk are required to follow enhanced precautions for a 42-day monitoring period following their last possible exposure. The guidance for these individuals is stringent, designed to prevent any accidental transmission within the community.
- Home Isolation: High-risk contacts are advised to stay home, limit contact with others, and avoid visiting public buildings.
- Residential Precautions: Those living with others are encouraged to use separate sleeping and bathroom spaces.
- Protective Measures: The CDC recommends frequent hand hygiene, improving indoor ventilation, and wearing a well-fitting mask or respirator when around other people.
- Medical Coordination: Non-urgent medical appointments should be postponed. If urgent care is required, the individual must coordinate with their local health department in advance.
Testing Protocols and Laboratory Capacity
A critical component of the current response is the strategy for testing. The CDC has stated that it does not recommend testing individuals for the Andes virus unless they are experiencing symptoms. This approach avoids the complications of testing asymptomatic individuals who may not be infectious.
Testing is being conducted through a network of specialized labs. The CDC, several state laboratories, and Quest Diagnostics utilize serologic testing to detect antibodies in the blood, with a turnaround time of approximately 24 hours. For more specific detection, the University of Nebraska offers a CLIA-certified RT-PCR test that can identify actual particles of the Andes virus in a patient.
Some passengers are currently being monitored at specialized facilities, including the University of Nebraska Medical Center (UNMC) and Emory University in Atlanta. Dr. Jay Bhattacharya, a senior official carrying out the delegable duties of the CDC Director, noted that the U.S. Government, via the Administration for Strategic Preparedness and Response (ASPR), is funding the contracts for these facilities to ensure passengers receive care without personal financial burden.
Broader Global Health Surveillance
While the hantavirus response is a primary focus, the CDC is simultaneously managing other emerging threats. Dr. Bhattacharya informed the press that the agency is closely monitoring Ebola outbreaks in both Uganda and the Ituri province of the Democratic Republic of the Congo (DRC).
The agency is providing technical assistance to the Ministries of Health in both nations through its country offices. Officials noted that maintaining a strong global health infrastructure is essential to protecting the U.S., arguing that addressing outbreaks at their source reduces the likelihood of those threats reaching American shores.
The current situation regarding the Andes virus remains stable, with no domestic transmissions reported. The CDC will continue its active monitoring of all potentially exposed individuals until the 42-day window has closed for every person involved.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Please consult a healthcare provider or the CDC official website for personal health concerns.
The CDC is expected to provide further updates as the remaining monitored passengers complete their 42-day observation periods. We invite readers to share their thoughts or questions in the comments below.
